about
UK guidelines for the management of bone sarcomasReview of Osteosarcoma and Current ManagementIncidence and survival of malignant bone sarcomas in England 1979-2007.Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results ProgramNeoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patientsThe epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002Osteosarcoma Overview.Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.UK Guidelines for the Management of Bone Sarcomas.Outcome of patients with osteosarcoma over 40 years of age: is angiogenesis a marker of survival?Current strategies of chemotherapy in osteosarcomaOsteosarcoma in adolescents and adults: survival analysis with and without lung metastases.Using epidemiology and genomics to understand osteosarcoma etiology.Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcomaPerioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review.Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma.The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report.Osteosarcoma and acromegaly: a case report and review of the literature.Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions.Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.Primary osteosarcoma in patients older than 40 years of age.Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.Pathological fracture of the proximal femur in osteosarcoma: need for early radical surgery?Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma.State-of-the-art approach for bone sarcomas.Management and prognostic significance of pathological fractures through chondrosarcoma of the femur.An update on chemotherapy for osteosarcoma.Establishment and characterization of a novel osteosarcoma cell line: CHOS.Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.Primary right ventricular osteosarcomaThe Scandinavian Sarcoma Group: 30 years' experience.Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.Osteosarcomas of jaw: experience of a single centre.
P2860
Q26752425-AA984B61-9E14-4F14-B81A-86426FF817CEQ28077590-054A870F-56F9-4310-861D-0226B7525A2CQ33274226-1C58513C-0C9D-432E-8EB4-848C53A3599FQ33274572-BB16FE6C-A657-401F-906D-26AF212D1F8FQ33406382-A9B9B15B-179A-4AE5-80D3-97E2CB5B0C64Q33418510-69B8EA39-C590-4D0D-9E5F-18DB131A8141Q33626004-4148887B-4413-43D3-BD0E-52DD1255104DQ33725511-8045E9EC-A44A-46E2-9779-55C12B5963B4Q33735680-94E20AAC-1F97-40E0-9EFE-B22BBD8369D9Q34496992-FAAEC68D-F3E2-4A5C-8046-0DDFE58FBFF0Q34537676-4DD74F3E-E5AD-46F5-8422-C59D82D80057Q34569791-D902DF16-8C98-4283-BE1C-EC1D09343E38Q34603276-538F1EE6-11B9-496B-ACD2-731E9FB423CAQ34627943-1657CAE8-D9FE-4837-9EE6-768EBC0FCACAQ35138344-0FC61C93-4D8F-43F1-AEE5-D5C88D812A77Q35190158-31F18A81-51E9-4670-B9D6-8D340A2E00ACQ35848126-B09B543F-D146-447F-9A72-49D04ABF0E36Q36017075-D74C8290-244C-4E10-95A8-8432CAAF1541Q36537388-96C7DF83-30E1-4BF8-A748-7AEA79E2600EQ36688734-8A5BB7C1-AB2E-459C-8342-C8F392970001Q36720803-0D436FFB-4BD7-4B2E-B462-119140B39635Q36850963-7699CE8E-5F21-4EAA-BA76-2D8681E283B2Q36927145-CE1FD673-DA51-4698-9A32-797B682D3E29Q36946002-DB79A054-16E3-44D8-9FBA-73167A8A826BQ37219508-C2D670E8-5D28-48A8-B6E5-EC0C3EFA43A5Q37313194-96857398-77C4-46FC-A9CC-A4D6800E8243Q37489008-5992A0C6-1821-4EC7-ACF4-E219B8133F5DQ38004499-5BE55C5A-9451-4F0F-84EA-43665A8482E3Q38191274-936FADE8-6817-45F8-97E2-A62F08FD4ED1Q38208930-FBC8F5C3-EC55-4957-AF58-156D9EC08D46Q38364816-68443D35-EA36-4588-B381-96F25EE5D6CDQ38619114-F441C46D-8332-4405-B66C-683C98AA386DQ38782968-5C5C368C-2631-4CD4-9302-28A47A351B4DQ38950083-98FA7051-4D1C-482B-8A34-78DE796D99DCQ38956007-6643DF7E-3E2C-439C-B9AD-75A4C90A88FEQ42221598-E3DBAB79-C424-4D4C-B663-898F4932E89DQ43589203-FCDDF090-77B1-4663-85DE-68B120D18F21Q50608843-2A39751F-87CE-466C-8A13-9B3532C687F4Q50752817-95C5CECC-5330-449A-AB98-BBB5000C41C7Q51142781-90FAED44-4189-42B5-BC6D-248A31D5641B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Osteosarcoma over the age of forty.
@ast
Osteosarcoma over the age of forty.
@en
Osteosarcoma over the age of forty.
@nl
type
label
Osteosarcoma over the age of forty.
@ast
Osteosarcoma over the age of forty.
@en
Osteosarcoma over the age of forty.
@nl
prefLabel
Osteosarcoma over the age of forty.
@ast
Osteosarcoma over the age of forty.
@en
Osteosarcoma over the age of forty.
@nl
P2093
P1476
Osteosarcoma over the age of forty
@en
P2093
A M Taminiau
B Kempf-Bielack
G Folleras
J van der Eijken
M Dominkus
M San-Julian
M Szendroi
P304
P356
10.1016/S0959-8049(02)00478-1
P577
2003-01-01T00:00:00Z